Ferulic acid and benzothiazole dimer derivatives with high binding affinity to β-amyloid fibrils

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 14, 2007, Pages 4022-4025

  Byeon, Seong Rim ^a   Jin, Yun Jung ^a   Lim, Soo Jeong ^b   Lee, Ji Hoon ^a   Yoo, Kyung Ho ^a   Shin, Kye Jung ^a   Oh, Seung Jun ^b   Kim, Dong Jin ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

A fibrils; AD diagnostic probe; Benzothiazole dimer; Ferulic acid dimer

Indexed keywords

2 [4' (DIMETHYLAMINO)PHENYL] 6 IODOBENZOTHIAZOLE; 2 [4' (METHYLAMINO)PHENYL] 6 HYDROXYBENZOTHIAZOLE; AMIDE; AMYLOID BETA PROTEIN; BENZOTHIAZOLE DERIVATIVE; DIMER; FERULIC ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; DIAGNOSTIC VALUE; DRUG BINDING; DRUG BINDING SITE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; STRUCTURE ACTIVITY RELATION;

AMYLOID BETA-PROTEIN; BENZOTHIAZOLES; COUMARIC ACIDS; DIMERIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34250674908     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.04.079     Document Type: Article

References (27)

1. Kung H.F., Lee C., Zhuang Z., Kung M., Hou C., and Plössl K. J. Am. Chem. Soc. 123 (2001) 12740
2. Meyer-luemen M. Nat. Neurosci. 6 (2003) 1
3. Nussbaum R.L., and Ellis C.E.N. Engl. J. Med. 348 (2003) 1356
4. Hardy J., and Seloke D.J. Science 297 (2002) 353
5. Thorsett E.D., and Latimer L.H. Curr. Opin. Chem. Bio. 4 (2000) 377
6. Vickers J.C., and Dickson T.C. Prog. Neurobiol. 60 (2000) 139
7. Hammarstrom P., Wiseman R.L., Powers E.T., and Kelly J.W. Science 299 (2003) 713
8. Dominquez D.I., and Strooper B.D. Trends Pharmacol. Sci. 23 (2002) 324
9. Lashuel H.A., Petre B.M., Wall J., Simon M., Nowak R.J., Walz T., and Lansbury P.T. J. Mol. Biol. 322 (2002) 1089
10. Volles M.J., and Lansbury P.T. Biochemistry 42 (2003) 7871
11. Selkoe D.J. Nat. Biotechnol. 18 (2000) 823
12. Dekosky S.T., and Marek K. Science 302 (2003) 830
13. Kim, D. J.; Shin, K. J.; Yu, J. H.; Lee, H. S.; WO03099269.
14. Blennow K., and Zetterberg H. Nat. Med. 12 (2006) 753
15. Langer O., Dolle F., Vallet H., Halldin C., Vaufrey F., Fuseau C., Coulon C., Ottaviani M., Nagden K., Bottlaender M., Baziere B., and Crouzel C. Bioorg. Med. Chem. 9 (2001) 677
16. Lee C.W., Zhuang Z.-P., Kung M.-P., Plössl K., Skovronsky D.M., Gur T.L., Hou C., Trojanowski J.Q., Lee V.M.Y., and Kung H.F. J. Med. Chem. 44 (2001) 2270
17. Mathis C.A., Wang Y., and Klunk W.E. Curr. Pharm. Design 10 (2004) 1469
18. Mathis C.A., Wang Y., Holt D.P., Huang G.-F., Debnath M.L., and Klunk W.E. J. Med. Chem. 46 (2003) 2740
19. Clark M.A., Duffy K., Tibrewala J., and Lipard S.J. Org. Lett. 5 (2003) 2051
20. Brotin T., Devic T., Lesage A., Emsely L., and Collet A. Chem. Eur. J. 7 (2001) 1561
21. Lin A.J., and Kasina S.J. J. Heterocycl. Chem. 18 (1981) 759
22. Mignani S., Audiau F., Leblevec J., Nemecek C., Barreau M., Jimont P., and Gaererry C. Synth. Commun. 22 (1992) 2769
23. Walczynski K., Guryn R., Zuderveld O.P., and Timmerman H. Il Farmaco 29 (1994) 684
24. Li Z., and Luo F. Hauxue Yanjiu Yu Yingyong 13 (2001) 80
25. Shevelev S.A., Dalinger I.L., Cherkasova T.L., Plössl K., Trojanowski J.Q., and Lee W.M.Y. Tetrahedron Lett. 42 (2001) 8539
26. Zhuang Z.-P., Kung M.-P., Hou C., Skovronsky D.M., Gur T.L., Plössl K., Trojanowski J.Q., Lee V.M.Y., and Kung H.F. J. Med. Chem. 44 (2001) 1905
27. 2: C, 60.99; H, 5.12; N, 15.80; S, 18.09. Found: C, 61.04; H, 5.22; N, 15.81; S, 17.82.